Das BURDEN – Projekt: Die Bestimmung der finanziellen Auswirkungen von Antibiotikaresistenzen in Europa

Alanis, 2005, Resistance to antibiotics: are we in the post-antibiotic era?, Arch Med Res, 36, 697, 10.1016/j.arcmed.2005.06.009 Cosgrove, 2003, The impact of antimicrobial resistance on health and economic outcomes, Clin Infect Dis, 36, 1433, 10.1086/375081 Cosgrove, 2006, The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs, Clin Infect Dis, 42, S82, 10.1086/499406 Howard, 2005, The economic burden of drug resistance, Clin Infect Dis, 41, S283, 10.1086/430792 Jansen, 2006, Bacterial resistance: A sensitive issue: Complexity of the challenge and containment strategy in Europe, Drug Resist Updat, 9, 123, 10.1016/j.drup.2006.06.002 MacKenzie, 2005, ARPAC Steering Group: Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC), Clin Microbiol Infect, 11, 938, 10.1111/j.1469-0691.2005.01258.x McGowan, 2001, Economic impact of antimicrobial resistance, Emerg Infect Dis, 7, 286, 10.3201/eid0702.010228 Smith, 2002, Antimicrobial resistance: A global response, Bull World Health Organ, 80, 126 Smith, 2005, Assessing the macroeconomic impact of a healthcare problem: The application of computable general equilibrium analysis to antimicrobial resistance, J Health Econ, 24, 1055, 10.1016/j.jhealeco.2005.02.003